Healthcare private equity reached an estimated $115 billion in 2024. India became the largest market in Asia Pacific by ...

Our fair value estimate for WuXi is HKD 24.60 per share. WuXi has been growing at a CAGR of 53.3% for the past eight years. Although its USD 20.5 billion total backlog revenue supports our growth ...

We ran multiple prompts on three popular generative AI chatbots—OpenAI’s ChatGPT, Grok (developed by Elon Musk-led xAI), and ...

Samsung Biologics has extended its collaboration with LigaChem Biosciences for antibody-drug conjugate (ADC) services. The ...

Rocket Lab’s backlog expanded 80% YoY, with ~50% expected to convert to revenue within 12 months. Read why I maintain my buy ...

After holding leadership positions at contract manufacturers Patheon and Thermo Fisher Scientific, working in the food and ...

The Dundalk site was WuXi's first manufacturing investment in Europe and the company’s first investment of this scale outside ...